Search Results

There are 21897 results for: content related to: Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study

  1. You have free access to this content
    European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 619–644, C.C. Zouboulis, N. Desai, L. Emtestam, R.E. Hunger, D. Ioannides, I. Juhász, J. Lapins, L. Matusiak, E.P. Prens, J. Revuz, S. Schneider-Burrus, J.C. Szepietowski, H.H. van der Zee and G.B.E. Jemec

    Version of Record online : 30 JAN 2015, DOI: 10.1111/jdv.12966

  2. Nail Psoriasis, the unknown burden of disease

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 12, December 2014, Pages: 1690–1695, K.M.G. Klaassen, P.C.M. van de Kerkhof and M.C. Pasch

    Version of Record online : 15 JAN 2014, DOI: 10.1111/jdv.12368

  3. You have full text access to this OnlineOpen article
    Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria

    Journal of the European Academy of Dermatology and Venereology

    A.Y. Finlay, A.P. Kaplan, L.A. Beck, E.N. Antonova, M.-M. Balp, J. Zazzali, S. Khalil and M. Maurer

    Version of Record online : 19 JUL 2017, DOI: 10.1111/jdv.14384

  4. You have free access to this content
    Quality of life measurement in atopic dermatitis. Position paper of the European Academy of Dermatology and Venereology (EADV) Task Force on quality of life

    Journal of the European Academy of Dermatology and Venereology

    Volume 31, Issue 4, April 2017, Pages: 576–593, P.V. Chernyshov, L. Tomas-Aragones, L. Manolache, S.E. Marron, M.S. Salek, F. Poot, A.P. Oranje, A.Y. Finlay and on behalf of the EADV Quality of Life Task Force

    Version of Record online : 17 JAN 2017, DOI: 10.1111/jdv.14058

  5. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue S2, March 2016, Pages: 1–18, E. Daudén, L. Puig, C. Ferrándiz, J.L. Sánchez-Carazo, J.M. Hernanz-Hermosa and on behalf of the Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology

    Version of Record online : 26 JAN 2016, DOI: 10.1111/jdv.13542

  6. You have full text access to this OnlineOpen article
    A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 4, April 2014, Pages: 438–453, U. Mrowietz, E.M.G.J. de Jong, K. Kragballe, R. Langley, A. Nast, L. Puig, K. Reich, J. Schmitt and R.B. Warren

    Version of Record online : 26 FEB 2013, DOI: 10.1111/jdv.12118

  7. You have full text access to this OnlineOpen article
    Guidelines on the use of extracorporeal photopheresis

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue s1, January 2014, Pages: 1–37, R. Knobler, G. Berlin, P. Calzavara-Pinton, H. Greinix, P. Jaksch, L. Laroche, J. Ludvigsson, P. Quaglino, W. Reinisch, J. Scarisbrick, T. Schwarz, P. Wolf, P. Arenberger, C. Assaf, M. Bagot, M. Barr, A. Bohbot, L. Bruckner-Tuderman, B. Dreno, A. Enk, L. French, R. Gniadecki, H. Gollnick, M. Hertl, C. Jantschitsch, A. Jung, U. Just, C.-D. Klemke, U. Lippert, T. Luger, E. Papadavid, H. Pehamberger, A. Ranki, R. Stadler, W. Sterry, I.H. Wolf, M. Worm, J. Zic, C.C. Zouboulis and U. Hillen

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jdv.12311

  8. You have free access to this content
    Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study

    Journal of the European Academy of Dermatology and Venereology

    Volume 31, Issue 1, January 2017, Pages: 169–174, C. Richter, C. Trojahn, K. Hillmann, G. Dobos, V. Kanti, A. Vogt, U. Blume-Peytavi and J. Kottner

    Version of Record online : 9 JUL 2016, DOI: 10.1111/jdv.13757

  9. Sexual dysfunction in psoriasis: a systematic review

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 649–655, A. Molina-Leyva, J.J. Jiménez-Moleón, R. Naranjo-Sintes and J.C. Ruiz-Carrascosa

    Version of Record online : 26 NOV 2014, DOI: 10.1111/jdv.12845

  10. You have full text access to this OnlineOpen article
    Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials

    Journal of the European Academy of Dermatology and Venereology

    Volume 31, Issue 3, March 2017, Pages: 498–506, D. Thaçi, A. Kimball, P. Foley, Y. Poulin, E. Levi, R. Chen and S.R. Feldman

    Version of Record online : 10 OCT 2016, DOI: 10.1111/jdv.13918

  11. You have full text access to this OnlineOpen article
    Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 31, Issue 2, February 2017, Pages: 323–332, C.E.M. Griffiths, R. Vender, H. Sofen, L. Kircik, H. Tan, S.T. Rottinghaus, M. Bachinsky, L. Mallbris and C. Mamolo

    Version of Record online : 7 SEP 2016, DOI: 10.1111/jdv.13808

  12. Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 2, February 2014, Pages: 192–203, C. Mamolo, J. Harness, H. Tan and A. Menter

    Version of Record online : 7 JAN 2013, DOI: 10.1111/jdv.12081

  13. Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 7, July 2015, Pages: 1398–1405, F. Rencz, P. Holló, S. Kárpáti, M. Péntek, É. Remenyik, A. Szegedi, O. Balogh, E. Herédi, K. Herszényi, H. Jókai, V. Brodszky and L. Gulácsi

    Version of Record online : 10 DEC 2014, DOI: 10.1111/jdv.12884

  14. You have free access to this content
    Management and treatment of chronic urticaria (CU)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue S3, June 2015, Pages: 16–32, M. Maurer, M.K. Church, M. Gonçalo, G. Sussman and M. Sánchez-Borges

    Version of Record online : 4 JUN 2015, DOI: 10.1111/jdv.13198

  15. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis

    Journal of the European Academy of Dermatology and Venereology

    Volume 31, Issue 2, February 2017, Pages: 213–220, L. Puig, H. Thom, P. Mollon, H. Tian and G.S. Ramakrishna

    Version of Record online : 28 OCT 2016, DOI: 10.1111/jdv.14007

  16. A measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patients

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 2, February 2015, Pages: 249–254, G.E. Kim, E. Seidler and A.B. Kimball

    Version of Record online : 31 MAR 2014, DOI: 10.1111/jdv.12503

  17. Quality of life in patients with alopecia areata: a hospital-based cross-sectional study

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue 5, May 2016, Pages: 840–846, S. Janković, J. Perić, N. Maksimović, A. Ćirković, J. Marinković, J. Janković, V. Reljić and L. Medenica

    Version of Record online : 9 DEC 2015, DOI: 10.1111/jdv.13520

  18. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 3, March 2015, Pages: 452–456, D. Hägg, A. Sundström, M. Eriksson and M. Schmitt-Egenolf

    Version of Record online : 9 JUN 2014, DOI: 10.1111/jdv.12576

  19. Quality of life and disease severity in patients with atopic dermatitis

    Journal of the European Academy of Dermatology and Venereology

    Volume 30, Issue 10, October 2016, Pages: 1760–1767, J.G. Holm, T. Agner, M.-L. Clausen and S.F. Thomsen

    Version of Record online : 10 JUN 2016, DOI: 10.1111/jdv.13689

  20. Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3

    Journal of the European Academy of Dermatology and Venereology

    Volume 31, Issue 9, September 2017, Pages: 1483–1490, C.L. Leonardi, A. Blauvelt, H.L. Sofen, M. Gooderham, M. Augustin, R. Burge, B. Zhu and K. Reich

    Version of Record online : 28 JUN 2017, DOI: 10.1111/jdv.14211